Oral diseases, mycology and periodontal microbiology of HIV-1-infected women

Oral Microbiology and Immunology

Volumn 11, Issue 6, 1996, Pages 371-380

  Brady, L J ^a   Walker, C ^a   Oxford, G E ^a   Stewart, C ^a   Magnusson, I ^a   McArthur, W ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

AIDS; CD4+T lymphocytes; HIV 1; Microbiology; Mycology; Oral candidiasis; Oral health; Periodontitis; Women

Indexed keywords

EID: 0030402910     PISSN: 09020055     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-302X.1996.tb00198.x     Document Type: Article

References (71)

1. Barone R, Ficarro G, Gaglioti D, Orsi A, Mazzotta F. Prevalence of oral lesions among HIV-infected intravenous drug abusers and other risk groups. Oral Surg Oral Med Oral Pathol 1990; 69: 169-173.
2. Barr C, Lopea MR, Rua-Dobles A, Miller LK, Mathur-Wagh U. Turgeon LR. HIV-associated oral lesions; immunologic virologicand salivary parameters. J Oral Pathol Med 1992; 21: 295-298.
3. Brehmer-Anderson E, Lucht E, Lindskog S, Ekman M, Beberrfeld P. Oral hairy leukoplakia: pathogenic aspects and significance of the lesion. Acta Derm Venerol (Stockh) 1994; 74: 81-89.
4. Carpenter CCJ, Mayer KH, Stein MD, Leibman BD, Fisher A, Fiore TC. Human immunodeficiency virus infection in North American women: experience with 200 cases and a review of the literature. Medicine 1991; 70: 307-325.
5. Cassone A, Boccanera M, Adnani D, Santom G, de Bernardis F. Rats clearing a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal reinfection. Infect Immun 1995; 63: 2619-2624.
6. Centers for Disease Control. AIDS in women - United States. MMWR Morb Mortal Wkly Rep 1990; 39: 845-846.
7. Centers for Disease Control and Prevention. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and aduits. MMWR Morb Mortal Wkly Rep 1993; 41: 1-19.
8. Centers for Disease Control and Prevention. Update: AIDS among women - United States, 1994. MMWR Morb Mortal Wkly Rep 1995; 44: 81-84.
9. Ch SY, Buehler JW, Berkelman RL. Impact of the human immundeficiency virus on mortality in women of reproductive age. JAMA 1990; 264: 225-229.
10. Challacombe SJ. Immunology of oral candidiasis. In: Samaranayake LP, Mac-Farlane TW, ed. Oral candidiasis. London: Butterworth, 1990: 133-155.
11. Clark RA, Brandon W, Dumestre J, Pindaro C. Clinical manifestations of infection with human immunodeficiency virus in women in Louisiana. Clin Infect Dis 1993; 17: 165-172.
12. Conti L, Lieb S, Spradling T, Witte JJ. AIDS epidemic among Florida women. J Fla Med Assoc 1993; 80: 246-249.
13. Coogan MM, Sweet SP, Challacombe SJ. Immunoglobulin A (IgA). IgA1, and IgA2 antibodies to Candida albicans in whole and parotid saliva in human immunodeficiency virus infection and AIDS. Infect Immun 1994; 62: 892-896.
14. Cowan DN, Brundage JF, Poraerantx RS. HIV infection among women in the Army Reserve components. J Acquire Immune Defic Svndr Hum Retrovirol 1994; 7: 171-176.
15. Cross DL, Smith GLF. Comparison of periodontal disease in HIV seropositive subjects and controls. II. Microbiology, immunology and predictors of disease progression. J Clin Periodontol 1995; 22: 569-577.
16. Crowe SM, Carlin JB, Stewart KI, Lucas CR, Hoy JF. Predictive value of CD4 lymphocyte numbers for the development of oppoutunistic infections and malignancies in HIV-infected persons. J Acquire Immune Defic Syndr Hum Retrovirol 1991:4:770-776.
17. Deepe GS, Bullock WE. Immunological aspects of fungal pathogenesis. Eur J Clin Microbiol Infect Dis 1990; 9: 377-380.
18. EEC clearinghouse on oral problems related to HIV infection and WHO Collaborating Centre on Oral Manifestations of the Human Immunodeficiency Virus. An update of the classification and diagnostic criteria of oral lesions and HIV infection. J Oral Pathol Med 1991; 20: 97-100.
19. Ellerbrock TV, Bush TJ. Chamberland ME, Oxtoby MJ. Epidemiology of women with AIDS in the United States. 1981 through 1990. a comparison with heterosexual men with AIDS. JAMA 1991; 265: 2971-2975.
20. Felix DH, Wray D. The prevalence of oral candidiasis in HIV-infected individuals and dental attenders in Edinburgh. J Oral Pathol Med 1993; 22: 418-420.
21. Fidel PL, Lynch ME, Sobel JD. Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasis. Infect Immun 1995; 63: 2403-2408.
22. Fidel PL, Lynch, ME, Conaway DH, Tait L, Sobel JD. Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity. Infect Immun 1995; 63: 547-553.
23. Fleming PL, Ciesielski CA, Byers RH, Castro KG, Berkelman RL. Gender differences in reported AIDS-indicative diagnoses. J Infect Dis 1993; 168: 61-67.
24. Gillespie G, Marino, R. Oral manifestations of HIV infection: a Panamerican perspective. J Oral Pathol Med 1993; 22: 2-7.
25. Grbic JT, Mitchell-Lewis DA. Fine JB et al. The relationship of candidiasis to linear gingival erythema in HIV-infected homosexual men and parenteral drug users. J Periodontol 1995; 66: 30-37.
26. Greenspan JS. Periodontal complications of HIV infection. Compendium 1993; 15(suppl 18): 694-698.
27. Greenspan JS, Barr CE, Sciubba JJ. Winkler JR. USA Oral AIDS Collaborative Group. Oral manifestations of HIV infection: definitions diagnostic criteria, and principles of therapy. Oral Surg Oral Med Oral Pathol 1992; 73: 142-144.
28. Hammond BF, Mallonee D. A selective/differential medium for Wolinella recta. J Dent Res 1988; 67: 327 (abstr 1712).
29. Holdeman LV, Cato EP, Moore WEC. Anaerobe laboratory manual. Blacksburg. VA. V.P.I. Anaerobe Laboratory, 1977.
30. Holmstrup P, Samaranayake LP. Acute and AIDS-related oral candidiasis. In: Samaranyake LP. MacFarlane TW, ed. Oral candidiasis. London: Butterworth, 1990: 133-155.
31. Holmstrup P, Westergaard J. Periodontal diseases in HIV-infected patients. J Clin Periodontol 1994; 21: 270-280.
32. Iman N, Carpenter CCJ, Mayer KH, Fisher A, Stein M, Danforth S. Hierarchical pattern of mucosal Candida infections in HIV-seropositive women. Am J Med 1990; 86: 142-146.
33. Itin PH, Lautenschlager S, Flückiger R, Ruffli T. Oral manifestations in HIV-1 infected patients: diagnosis and management. J Am Acad Dermatol 1993; 29: 749-760.
34. Katz MH, Greenspan D. Westenhouse J et al. Progression to AIDS in HIV-infected homosexual and bisexual men with hairy leukoplakia and oral candidiasis. AIDS 1992; 6: 95-100.
35. Lifson AR, Hilton JF, Westenhouse JL et al. Time from HIV seroconversion to oral candidiasis or hairy leukoplakia among homosexual and bisexual men enrolled in three prospective cohorts. AIDS 1994; 8: 73-79.
36. MacFaddin JF. Mitis salivarius (MS) agar. In: Media, for isolation-cultivation-identification-maintenance of medical bacteria. Baltimore. MD: Williams & Wilkins. 1985: 522-526.
37. Madden C, Hopkins SG, Lafferty WE. Progression to AIDS or death following diagnosis with a class IV non-AIDS disease. J Acquire Immune Dene Syndr Hum Retrovirol 1994; 7: 972-977.
38. Melnick SL, Engel D, Truelove E et al. Oral mucosal lesions: association with the presence of antibodies to the human immunodeficiency virus. Oral Surg Oral Med Oral Pathol 1989; 68: 37-43.
39. Moniaci D, Greco D, Flecchia G. Sinnicco A. Epidemiology, clinical features and prognostic value of HIV-1 related oral lesions. J Oral Pathol Med 1990; 19: 477-481.
40. Moore LVH, Bourne DM, Moore WEC. Comparative distribution and taxonomic value of cellular fatty acids in thirtythree genera of anaerobic gram-negative bacilli. Int J Syst Bacteriol 1994; 44: 338-347.
41. Moore LVH, Moore WEC, Riley C, Brooks CN, Burmister JA. Smibert RM. Periodontal microflora of HIV positive subjects with gingivitis or adult periodontitis. J Periodontol 1993; 64: 48-56.
42. Mosier, DE. Consequences of secondary or co-infections for immunity. Curr Opin Immunol 1994; 6: 539-544.
43. Murray PA., Winkler JR, Peros WJ, French CK, Lippke JA. DNA probe detection of periodontal pathogens in HIV-associated periodontal lesions. Oral Microbiol Immunol 1991; 6: 34-10.
44. Nielsen H, Bentsen KD, Höjtved L et al. Oral candidiasis and immune status of HIV-infected patients. J Oral Pathol Med 1994; 23: 140-143.
45. Odden K, Schenck K, Koppang HS, Hurlen B. Candidal infection of the gingiva in HIV-infected persons. J Oral Pathol Med 1994; 23: 178-183.
46. Odds FC. Chronic mucocutaneous candidosis. In: Odds FC. ed. Candida and candidoisis. 2nd edn. Philadelphia: Bailliere Tindall, 1988: 148-150.
47. Pantaleo G, Fauci AS. New concepts in the immunopathogenesis of HIV infection. Annu Rev Immunol 1995; 13: 487-512.
48. Peterman TA, Jaffe HA, Beral V. Epidemiologic clues to the etiology of Kaposi's sarcoma. AIDS 1993; 7: 605-611.
49. Phelan JA, Salzman BR, Friedland GH, Klein RS. Oral findings m patients with acquired immunodeficiency syndrome. Oral Surg Oral Med Oral Pathol 1987; 64: 50-56.
50. Rams TE, Andriolo M Jr, Feik D, Abel SM, McGivern TM, Slots J. Microbiological study of HIV-related periodontitis. J Periodontol 1991; 62: 74-81.
51. Robinson P. Periodontal diseases and HIV infection. A review of the literature. J Clin Periodontol 1992; 19: 609-614.
52. Samaranayake LP. Oral mycoses in HIV infection. Oral Surg Oral Med Oral Pathol 1992; 73: 171-180.
53. Schiodt M. HIV-associated salivary gland disease: a review. Oral Surg Oral Med Oral Pathol 1992; 73: 164-167.
54. Selwyn PA, Alcabes P, Hartel D et al. Clinical manifestations and predictors of disease progression in drup users with human immunodeficiency virus infection. N Engl J Med 1992; 327. 1697-1703.
55. Sha BE, Benson CA. Pottage, JC, Urbanski PA, Daugherty SR, Kessler HA. HIV infection in women: an observational study of clinical characteristics, disease progression, and survival for a cohort of women in Chicago. J Acquire Immune Defic Syndr Hum Retrovirol 1995; 8: 486-495.
56. Shiboski CH, Hilton JF, Greenspan D et al. HIV-related oral manifestations in two cohorts of women in San Francisco. J Acquire Immune Defic Syndr Hum Retrovirol 1994; 7: 964-971.
57. Slots J. Selective medium for isolation of Actinobacillus actinomycelemcomitans. J Clin Microbiol 1982; 15: 606-609.
58. Smith GLF, Cross DL, Wray D. Comparison of periodontal disease in HIV seropositive subjects and controls. I. Clinical features. J Clin Periodontol 1995; 22: 558-568.
59. Sobel JD. Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann N Y Acad Sci 1988; 544: 547-557.
60. Stoneburner RL, Sato P, Burton A, Mertens T. The global HIV pandemic. Acta Paediatr 1994; 400: 1-4.
61. Sweeney PA, Onorato IM, Allen DM, Byers RH, the Field Services Branch. Sentinel surveillance of human immunodeficiency virus infection in women seeking reproductive health services in the United States, 1988-1989. Obstet Gynecol 1992; 79: 503-510.
62. VanDyke TE, Hoop GA. Neutrophil function and oral disease. Crit Rev Oral Biological Med 1990; 1: 117-133.
63. Walker C. Antimicrobial agents and chemotherapy. In: Slots J, Taubman MA, ed. Contemporary oral microbiology and immunology. St. Louis: Mosby-Year Book, 1992: 242-264.
64. Walker CB, Socransky SS. A selective medium for Fusobacterium nucleatum from human periodontal pockets. J Clin Microbiol 1979; 10: 844-849.
65. Walker CB, Tanner ACR, Smith C, Socransky SS. Selective medium for Eikenella corrodens. J Dent Res 1978; 57: Abstr. 961.
66. Wanzala P, Manji F, Pindborg JJ, Plummer F. Low prevalence of oral mucosal lesions in HIV-1 seropositive African women. J Oral Pathol Med 1989; 18: 416-418.
67. Winkler JA, Grassi M, Murray PA. Clinical description and etiology of HTV-associated periodomal diseases. In: Robertson PB, Greenspan JS, ed. Perspectives on oral manifestations of AIDS. San Diego, CA: PSG Publishing Co., 1988: 49-70.
68. Wyss C. Dependence of proliferation of Bacteroides forsythus on exogenous N-acetylmuramic acid. Infect Immun 1989; 57: 1757-1759.
69. Yeung SCH, Stewart GJ, Cooper DA, Sindhusake D. Progression of periodontal disease in HIV seropositive patients. J Periodontol 1993; 64: 651-657.
70. Zambon JJ, Reynolds HS, Genco RJ. Studies of the subgingival microflora in patients with acquired immunodeficiency syndrome. J Periodontol 1990; 61: 699-704.
71. Zylher L, Jordan H. Development of a partially selective medium for Actinomyces viscosus and A. naeslundii. J Clin Microbiol 1982; 15: 253-259.